» Articles » PMID: 37564455

Kidney Allograft Rejection and Coronavirus Disease 2019 Infection: A Narrative Review

Overview
Journal Adv Biomed Res
Date 2023 Aug 11
PMID 37564455
Authors
Affiliations
Soon will be listed here.
Abstract

The world has experienced a global medical and socioeconomic burden following the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 is a systemic disease and may affect different organs including the kidneys. Current literature contains reports on COVID-19-related conditions such as acute kidney injury, and complications experienced by chronic kidney disease, end stage kidney disease, and kidney transplant patients. Here, we discuss the incidence of kidney allograft rejection, immunosuppression management and rejection risk, donor-specific antibodies and previous rejection episodes, and rejection outcomes in kidney transplant recipients with COVID-19 by reviewing current studies.

Citing Articles

Adequacy to immunosuppression management guidelines in kidney transplant recipients with severe COVID-19 pneumonia: a practice survey.

Jacq A, Auvray C, Blot M, Bouhemad B, Casenaz A, Lamarthee B Front Transplant. 2024; 3:1305152.

PMID: 38993755 PMC: 11235282. DOI: 10.3389/frtra.2024.1305152.

References
1.
Jordan S, Ammerman N, Choi J, Kumar S, Huang E, Toyoda M . Interleukin-6: An Important Mediator of Allograft Injury. Transplantation. 2020; 104(12):2497-2506. DOI: 10.1097/TP.0000000000003249. View

2.
Chavarot N, Gueguen J, Bonnet G, Jdidou M, Trimaille A, Burger C . COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities. Am J Transplant. 2020; 21(3):1285-1294. PMC: 7753406. DOI: 10.1111/ajt.16416. View

3.
Kute V, Bhalla A, Guleria S, Ray D, Bahadur M, Shingare A . Clinical Profile and Outcome of COVID-19 in 250 Kidney Transplant Recipients: A Multicenter Cohort Study From India. Transplantation. 2020; 105(4):851-860. PMC: 7993652. DOI: 10.1097/TP.0000000000003593. View

4.
Yang C, Shih C, Yang W, Lin C . Aggressive immunosuppressant reduction and long-term rejection risk in renal transplant recipients with Pneumocystis jiroveci pneumonia. Exp Clin Transplant. 2012; 10(4):344-9. DOI: 10.6002/ect.2012.0015. View

5.
Shih C, Tarng D, Yang W, Yang C . Immunosuppressant dose reduction and long-term rejection risk in renal transplant recipients with severe bacterial pneumonia. Singapore Med J. 2014; 55(7):372-7. PMC: 4291963. DOI: 10.11622/smedj.2014089. View